Sight Diagnostics scoops up $71m Series D
Sight Diagnostics, an Israeli developer of blood analyzers, has raised $71 million in Series D funding.
Sight Diagnostics, an Israeli developer of blood analyzers, has raised $71 million in Series D funding.
Copyright PEI Media
Not for publication, email or dissemination
